and European regulators reviewed safety reports involving patients using GLP-1 medications
Quick Answer: Tirzepatide does not directly cause sleeplessness as a recognised adverse effect, though sleep disturbances may occur indirectly through gastrointestinal symptoms or metabolic changes
Manufacturers are in the process of making new GLP-1s that are easier to produce, store, and administer
With no insurance requirements, no waitlists, and no hidden fees, the service provides an affordable alternative to branded medications that can cost over $1,000 monthly
GLP-1 RA Cohort Similarly to the SGLT2i cohort, notable proportions of GLP-1 RA new users were missing results for eGFR (37.1%), CKD stage diagnosis codes (37.6%), and uACR (75.2%) (Supplemental Table S5)
Masstort or MDL